Clinical Trial Update: Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment [NA]

View source ↗

Summary

This trial update reports on visual acuity outcomes in patients with polypoidal choroidal vasculopathy treated with aflibercept, in a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Polypoidal Choroidal Vasculopathy | NA | Status: COMPLETED